The State of Utah v. APOTEX CORPORATION; BAXTER HEALTHCARE CORPORATION; BOEHRINGERINGELHEIM CORPORATION; MALLINCKRODT INC.; CSL BEHRING; FOREST ABORATORIES, INC.; MORTON GROVE PHARMACEUTICALS, INC.; MUTUAL PHARMACEUTICAL COMPANY, INC.; NOVARTIS PHARMACEUTICALS CORPORATION; OTSUKA AMERICA, INC.; PFIZER, INC.; QUALITEST PHARMACEUTICALS, INC.; SCHERING-PLOUGH CORPORATION; SCHWARZ PHARMA USA HOLDINGS, INC; TARO PHARMACEUTICALS USA, INC.; UPSHER-SMITH, INC.; and WYETH, INC. : Reply Brief

Authors

Utah Court of Appeals

Docket Number

20100257

Document Type

Reply Brief

Publication Date

2010

Comments

Original Brief Submitted to the Utah Court of Appeals; digitized by the Howard W. Hunter Law Library, J. Reuben Clark Law School, Brigham Young University, Provo, Utah; machine-generated OCR, may contain errors.
R. James DeRose III; Locke, Lord, Bissell and Liddell; Counsel for Appellees.
Joseph W. Steele; David C. Biggs; Steele and Biggs; Special Assistant Attorneys General; Counsel for Appellant.

Rights

Public record document (some rights may be reserved).

Recommended Citation

Reply Brief, Utah v. Apotex Corporation, No. 20100257 (Utah Court of Appeals, 2010).
https://digitalcommons.law.byu.edu/byu_ca3/2258